Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.41 |
| ▸ | CA1 | P00915 | 5/20 | 0.41 |
| ▸ | CA2 | P00918 | 5/20 | 0.41 |
| ▸ | CA9 | Q16790 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TYMP | P19971 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | KCNA4 | P22459 | 1/20 | 0.32 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.32 |
| ▸ | KCNAB1 | Q14722 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18589182 | 0.89 | CA12 (0.42) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL14822595 | 0.88 | LMNA (0.43) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL14822583 | 0.88 | CA12 (0.41) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL18577912 | 0.84 | CA12 (0.39) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL18823118 | 0.84 | CA12 (0.47) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL29705195 | 0.82 | CA12 (0.37) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL15899409 | 0.81 | CA12 (0.37) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL15899355 | 0.80 | CA12 (0.44) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL14822596 | 0.80 | CA12 (0.44) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL14822353 | 0.78 | CA12 (0.39) | CA12CA1CA2CA9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4282857-B1 | RADIOACTIVE HALOGEN-LABELED PRECURSOR COMPOUND | INST OF SCIENCE TOKYO (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-20240034721-A1 | RADIOACTIVE HALOGEN LABELING PRECURSOR COMPOUND | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2024-02-01 | — | — | US | disclosed |
| EP-4282857-A1 | RADIOACTIVE HALOGEN-LABELED PRECURSOR COMPOUND | Tokyo Institute of Technology (JP) | 2023-11-29 | — | — | EP | disclosed |
| WO-2022158442-A1 | RADIOACTIVE HALOGEN-LABELED PRECURSOR COMPOUND | 国立大学法人東京工業大学 | 2022-07-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240034721-A1 | RADIOACTIVE HALOGEN LABELING PRECURSOR COMPOUND | GPR119, SLC5A2, GCKR | CA12 616/4885CA1 1611/4885CA2 2854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.